Sanford J. Hillsberg
Directeur/Membre du Conseil chez Tempra Technology, Inc.
Profil
Sanford J.
Hillsberg was the founder and Chairman of Nacuity Pharmaceuticals, Inc. founded in 2017.
He is currently a Director at Tempra Technology, Inc. since 1997 and a Principal at TroyGould PC.
Mr. Hillsberg was the Chairman of Galena Biopharma, Inc. from 2007 to 2017, Secretary & Director at Cordex Pharma, Inc. in 2006, Independent Director at Iovance Biotherapeutics, Inc. from 2013 to 2018, and Secretary at ImmunoCellular Therapeutics Ltd.
from 2004 to 2007.
He was also a Commissioner at Los Angeles Quality & Productivity Commission.
Mr. Hillsberg received his undergraduate degree from the University of Pennsylvania and his graduate degree from Harvard Law School.
Mr. Hillsberg is also the founder of King Pharmaceuticals Research & Development, Inc. founded in an unknown year.
Postes actifs de Sanford J. Hillsberg
| Sociétés | Poste | Début |
|---|---|---|
Tempra Technology, Inc.
 Tempra Technology, Inc. Building ProductsProducer Manufacturing Tempra Technology, Inc. is a research and development applications company based in an undisclosed location. The private company is based in Bradenton, FL. Tempra Technology has developed and patented both self-cooling and self-heating technologies, making them a leader in the development of instant, self-heating and self-chilling product technology. The company has developed innovative products for food & beverage, medical, therapy, sports medicine, equestrian and consumer product markets. Tempra Technology was the first company to develop a completely functional, 100% safe, environmentally friendly self-chilling beverage can. The company has also developed self-heating technologies for hand-held foods such as soups, beverages, pasta dishes, and sauces. Additionally, Tempra Technology offers instant self-heating and self-chilling gel packs and a variety of thermal wraps. All of their products are designed to provide instant, portable, safe, long-lasting thermal technology anytime, anywhere. The company was founded in 1992 by Barney J. Guarino, who has been the CEO since then. | Directeur/Membre du Conseil | 01/01/1997 |
TroyGould PC
 TroyGould PC Miscellaneous Commercial ServicesCommercial Services TroyGould PC engages in the provision of legal services. It offers a wide range of transactional and compliance matters for both public companies and privately held businesses operating in numerous industries such as entertainment and new media, food and beverages, intellectual property (IP)and technology, life sciences, litigation, and real estate. The company is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
Anciens postes connus de Sanford J. Hillsberg
| Sociétés | Poste | Fin |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 06/06/2018 |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Président | 29/12/2017 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Secrétaire Général | 01/12/2007 |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | 01/01/2006 |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Fondateur | - |
Formation de Sanford J. Hillsberg
| University of Pennsylvania | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
| King Pharmaceuticals Research & Development, Inc. | Health Technology |
Tempra Technology, Inc.
Tempra Technology, Inc. Building ProductsProducer Manufacturing Tempra Technology, Inc. is a research and development applications company based in an undisclosed location. The private company is based in Bradenton, FL. Tempra Technology has developed and patented both self-cooling and self-heating technologies, making them a leader in the development of instant, self-heating and self-chilling product technology. The company has developed innovative products for food & beverage, medical, therapy, sports medicine, equestrian and consumer product markets. Tempra Technology was the first company to develop a completely functional, 100% safe, environmentally friendly self-chilling beverage can. The company has also developed self-heating technologies for hand-held foods such as soups, beverages, pasta dishes, and sauces. Additionally, Tempra Technology offers instant self-heating and self-chilling gel packs and a variety of thermal wraps. All of their products are designed to provide instant, portable, safe, long-lasting thermal technology anytime, anywhere. The company was founded in 1992 by Barney J. Guarino, who has been the CEO since then. | Producer Manufacturing |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
TroyGould PC
TroyGould PC Miscellaneous Commercial ServicesCommercial Services TroyGould PC engages in the provision of legal services. It offers a wide range of transactional and compliance matters for both public companies and privately held businesses operating in numerous industries such as entertainment and new media, food and beverages, intellectual property (IP)and technology, life sciences, litigation, and real estate. The company is headquartered in Los Angeles, CA. | Commercial Services |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
| Los Angeles Quality & Productivity Commission | Government |
Nacuity Pharmaceuticals, Inc.
Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nacuity Pharmaceuticals, Inc. develops and markets pharmaceutical products. The company is headquartered in Fort Worth, TX. | Health Technology |
